Global Epidemiology Forecasting Director (Hybrid)

Vertex Pharmaceuticals Incorporated; Boston (MA); Hybrid; USD 192,000 - 288,000; Full time

Benefits offered by this job

Total Rewards benefits

401(k)

Commuting subsidy

Student loan repayment

Job summary

Vertex Pharmaceuticals Incorporated seeks a Director, Epidemiology Forecasting to lead strategic plans for global incidence, prevalence, and population size estimates across disease areas in development.

You will oversee systematic literature reviews, database studies, and primary observational research, and collaborate with commercial, medical, regulatory, and corporate communications to align investments and deliver high-quality epi deliverables.

Qualifications

• PhD/DrPH in Epidemiology or related discipline with substantial industry experience.
• Experience developing disease population size estimates.
• Experience conducting systematic literature reviews and primary observational studies.

Responsibilities

• Lead systematic literature reviews and database/disease registry studies to estimate disease incidence, prevalence, and population size.
• Generate quality global estimates of disease incidence, prevalence, and population size.
• Collaborate with cross-functional partners in commercial, business development, medical, clinical, regulatory, corporate communications, and other functions.
• Support internal processes and align strategic plans and investment levels to ensure epi deliverables meet organizational needs.
• Develop innovative solutions to provide relevant epidemiologic information where evidence is sparse.

Skills

Exceptional written and oral comms

Cross-functional collaboration

Strategic planning

Education

PhD/DrPH/DSc in Epidemiology

MPH/ MSc with 12+ years experience

Job description

Vertex Pharmaceuticals Incorporated seeks a Director, Epidemiology Forecasting to lead strategic plans for global incidence, prevalence, and population size estimates across disease areas in development.

You will oversee systematic literature reviews, database studies, and primary observational research, and collaborate with commercial, medical, regulatory, and corporate communications to align investments and deliver high-quality epi deliverables.